Heart experts clash on Vytorin and cancer risk

Cancer, General Health, Health Headlines, Heart Health, Men's Health, Woman's Health
Reuters is reporting that experts are clashing over the safety of the cholesterol drug Vytorin as full results from a controversial study were presented at Europe's biggest medical congress. Researchers involved in the so-called SEAS study – highlights of which were first released in July – said there was no credible evidence linking Vytorin to cancer and that the higher number of cases seen in the trial was simply a fluke. My Take? (more…)
Read More